Kutzker T - Search Results

1

An Innovative Non-Linear Prediction Model for Clinical Benefit in Women with Newly Diagnosed Breast Cancer Using Baseline FDG-PET/CT and Clinical Data.

Kudura K, Ritz N, Templeton AJ, Kutzker T, Hoffmann MHK, Antwi K, Zwahlen DR, Kreissl MC, Foerster R. Kudura K, et al. Among authors: kutzker t. Cancers (Basel). 2023 Nov 20;15(22):5476. doi: 10.3390/cancers15225476. Cancers (Basel). 2023. PMID: 38001736 Free PMC article.

2

Predictive Value of Total Metabolic Tumor Burden Prior to Treatment in NSCLC Patients Treated with Immune Checkpoint Inhibition.

Kudura K, Ritz N, Templeton AJ, Kutzker T, Foerster R, Antwi K, Kreissl MC, Hoffmann MHK. Kudura K, et al. Among authors: kutzker t. J Clin Med. 2023 May 28;12(11):3725. doi: 10.3390/jcm12113725. J Clin Med. 2023. PMID: 37297920 Free PMC article.

3

Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival.

Kudura K, Ritz N, Templeton AJ, Kissling M, Kutzker T, Foerster R, Hoffmann MHK, Antwi K, Kreissl MC. Kudura K, et al. Among authors: kutzker t. Cancers (Basel). 2023 Feb 28;15(5):1521. doi: 10.3390/cancers15051521. Cancers (Basel). 2023. PMID: 36900312 Free PMC article.

4

Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors.

Kudura K, Ritz N, Kutzker T, Hoffmann MHK, Templeton AJ, Foerster R, Kreissl MC, Antwi K. Kudura K, et al. Among authors: kutzker t. Cancers (Basel). 2022 Dec 11;14(24):6095. doi: 10.3390/cancers14246095. Cancers (Basel). 2022. PMID: 36551581 Free PMC article.

5

Correction: Kudura et al. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. Cancers 2021, 13, 3830.

Kudura K, Dimitriou F, Basler L, Förster R, Mihic-Probst D, Kutzker T, Dummer R, Mangana J, Burger IA, Kreissl MC. Kudura K, et al. Among authors: kutzker t. Cancers (Basel). 2022 Jul 4;14(13):3268. doi: 10.3390/cancers14133268. Cancers (Basel). 2022. PMID: 35805065 Free PMC article.

6

Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients.

Kudura K, Dimitriou F, Basler L, Förster R, Mihic-Probst D, Kutzker T, Dummer R, Mangana J, Burger IA, Kreissl MC. Kudura K, et al. Among authors: kutzker t. Cancers (Basel). 2021 Jul 29;13(15):3830. doi: 10.3390/cancers13153830. Cancers (Basel). 2021. PMID: 34359730 Free PMC article.

7

Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients.

Kudura K, Dimitriou F, Mihic-Probst D, Muehlematter UJ, Kutzker T, Basler L, Förster R, Dummer R, Mangana J, Husmann L, Burger IA, Kreissl MC. Kudura K, et al. Among authors: kutzker t. Diagnostics (Basel). 2021 May 15;11(5):883. doi: 10.3390/diagnostics11050883. Diagnostics (Basel). 2021. PMID: 34063555 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters